Lifestyle management of polycystic ovary syndrome: a single-center study in Bosnia and Herzegovina

Jasmina Djedjibegovic; Aleksandra Marjanovic; Ilhana Kobilica; Amila Turalic; Aida Lugusic; Miroslav Sober; Jasmina Djedjibegovic; Aleksandra Marjanovic; Ilhana Kobilica; Amila Turalic; Aida Lugusic; Miroslav Sober

doi:10.3934/publichealth.2020041

AIMS Public Health

2020, Volume 7, Issue 3: 504-520. doi: 10.3934/publichealth.2020041

Previous Article Next Article

Research article Special Issues

Lifestyle management of polycystic ovary syndrome: a single-center study in Bosnia and Herzegovina

Faculty of Pharmacy, University of Sarajevo, Sarajevo, Bosnia and Herzegovina

Received: 17 May 2020 Accepted: 07 July 2020 Published: 08 July 2020

Keywords:

Citation: Jasmina Djedjibegovic, Aleksandra Marjanovic, Ilhana Kobilica, Amila Turalic, Aida Lugusic, Miroslav Sober. Lifestyle management of polycystic ovary syndrome: a single-center study in Bosnia and Herzegovina[J]. AIMS Public Health, 2020, 7(3): 504-520. doi: 10.3934/publichealth.2020041

Related Papers:

[1]	Eunha Shim, Beth Kochin, Alison Galvani . Insights from epidemiological game theory into gender-specific vaccination against rubella. Mathematical Biosciences and Engineering, 2009, 6(4): 839-854. doi: 10.3934/mbe.2009.6.839
[2]	Hyun Mo Yang, André Ricardo Ribas Freitas . Biological view of vaccination described by mathematical modellings: from rubella to dengue vaccines. Mathematical Biosciences and Engineering, 2019, 16(4): 3195-3214. doi: 10.3934/mbe.2019159
[3]	Lili Liu, Xi Wang, Yazhi Li . Mathematical analysis and optimal control of an epidemic model with vaccination and different infectivity. Mathematical Biosciences and Engineering, 2023, 20(12): 20914-20938. doi: 10.3934/mbe.2023925
[4]	Pannathon Kreabkhontho, Watchara Teparos, Thitiya Theparod . Potential for eliminating COVID-19 in Thailand through third-dose vaccination: A modeling approach. Mathematical Biosciences and Engineering, 2024, 21(8): 6807-6828. doi: 10.3934/mbe.2024298
[5]	Eunha Shim . Optimal strategies of social distancing and vaccination against seasonal influenza. Mathematical Biosciences and Engineering, 2013, 10(5&6): 1615-1634. doi: 10.3934/mbe.2013.10.1615
[6]	Majid Jaberi-Douraki, Seyed M. Moghadas . Optimal control of vaccination dynamics during an influenza epidemic. Mathematical Biosciences and Engineering, 2014, 11(5): 1045-1063. doi: 10.3934/mbe.2014.11.1045
[7]	Xunyang Wang, Canyun Huang, Yuanjie Liu . A vertically transmitted epidemic model with two state-dependent pulse controls. Mathematical Biosciences and Engineering, 2022, 19(12): 13967-13987. doi: 10.3934/mbe.2022651
[8]	Hamed Karami, Pejman Sanaei, Alexandra Smirnova . Balancing mitigation strategies for viral outbreaks. Mathematical Biosciences and Engineering, 2024, 21(12): 7650-7687. doi: 10.3934/mbe.2024337
[9]	Lan Zou, Jing Chen, Shigui Ruan . Modeling and analyzing the transmission dynamics of visceral leishmaniasis. Mathematical Biosciences and Engineering, 2017, 14(5&6): 1585-1604. doi: 10.3934/mbe.2017082
[10]	Hai-Feng Huo, Tian Fu, Hong Xiang . Dynamics and optimal control of a Zika model with sexual and vertical transmissions. Mathematical Biosciences and Engineering, 2023, 20(5): 8279-8304. doi: 10.3934/mbe.2023361

Acknowledgments

The authors sincerely thank the Public Institution Health Centre of Sarajevo Canton for its cooperation and the physicians who devoted their time to complete the questionnaire.

Conflict of interest

There is no conflict of interest to be declared.

References

[1]	Dumesic DA, Oberfield SE, Stener-Victorin E, et al. (2015) Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr Rev 36: 487-525. doi: 10.1210/er.2015-1018
[2]	Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81: 19-25.
[3]	Brennan L, Teede H, Skouteris H, et al. (2017) Lifestyle and behavioral management of polycystic ovary syndrome. J Womens Health (Larchmt) 26: 836-848. doi: 10.1089/jwh.2016.5792
[4]	Teede H, Misso M, Costello M, et al. International evidence-based guideline for the assessment and management of polycystic ovary syndrome, 2018. Available from: https://www.monash.edu/__data/assets/pdf_file/0004/1412644/PCOS_Evidence-Based-Guidelines_20181009.pdf.
[5]	Costello MF, Misso M, Balen AH, et al. (2019) A brief update on the evidence supporting the treatment of infertility in polycystic ovary syndrome. Aust N Z J Obstet Gynaecol 59: 867-873. doi: 10.1111/ajo.13051
[6]	Tay CT, Moran LJ, Wijeyaratne CN, et al. (2018) Integrated model of care for polycystic ovary syndrome. Semin Reprod Med 36: 86-94. doi: 10.1055/s-0038-1667310
[7]	Conway G, Dewailly D, Diamanti-Kandarakis E, et al. (2014) European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group's Questionnaire. Eur J Endocrinol 171: 489-498. doi: 10.1530/EJE-14-0252
[8]	Blackshaw LCD, Chhour I, Stepto NK, et al. (2019) Barriers and facilitators to the implementation of evidence-based lifestyle management in polycystic ovary syndrome: a narrative review. Med Sci (Basel) 7: 76.
[9]	Arasu A, Moran LJ, Robinson T, et al. (2019) Barriers and facilitators to weight and lifestyle management in women with polycystic ovary syndrome: general practitioners' perspectives. Nutrients 11: 1024. doi: 10.3390/nu11051024
[10]	Taylor T, Scott A (2019) Do physicians prefer to complete online or mail surveys? Findings from a national longitudinal survey. Eval Health Prof 42: 41-70. doi: 10.1177/0163278718807744
[11]	Beebe TJ, Locke GR, Barnes SA, et al. (2007) Mixing web and mail methods in a survey of physicians. Health Serv Res 42: 1219-1234. doi: 10.1111/j.1475-6773.2006.00652.x
[12]	Cunningham CT, Quan H, Hemmelgarn B, et al. (2015) Exploring physician specialist response rates to web-based surveys. BMC Med Res Methodol 15: 32. doi: 10.1186/s12874-015-0016-z
[13]	Jatic Z, Erkocevic H, Trifunovic N, et al. (2019) Frequency and forms of workplace violence in primary health care. Med Arch 73: 6-10. doi: 10.5455/medarh.2019.73.6-10
[14]	Piltonen TT, Ruokojarvi M, Karro H, et al. (2019) Awareness of polycystic ovary syndrome among obstetrician-gynecologists and endocrinologists in Northern Europe. PLoS One 14: e0226074. doi: 10.1371/journal.pone.0226074
[15]	Diamanti-Kandarakis E, Dunaif A (2012) Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev 33: 981-1030. doi: 10.1210/er.2011-1034
[16]	Saxena P, Prakash A, Nigam A, et al. (2012) Polycystic ovary syndrome: is obesity a sine qua non? A clinical, hormonal, and metabolic assessment in relation to body mass index. Indian J Endocrinol Metab 16: 996-999. doi: 10.4103/2230-8210.103011
[17]	Lewandowski KC, Skowrońska-Jóźwiak E, Łukasiak K, et al. (2019) How much insulin resistance in polycystic ovary syndrome? Comparison of HOMA-IR and insulin resistance (Belfiore) index models. Arch Med Sci 15: 613-618. doi: 10.5114/aoms.2019.82672
[18]	Singla R, Gupta Y, Khemani M, et al. (2015) Thyroid disorders and polycystic ovary syndrome: An emerging relationship. Indian J Endocrinol Metab 19: 25-29. doi: 10.4103/2230-8210.146860
[19]	Tomlinson J, Pinkney J, Adams L, et al. (2017) The diagnosis and lived experience of polycystic ovary syndrome: A qualitative study. J Adv Nurs 73: 2318-2326. doi: 10.1111/jan.13300
[20]	Gibson-Helm ME, Lucas IM, Boyle JA, et al. (2014) Women's experiences of polycystic ovary syndrome diagnosis. Fam Pract 31: 545-549. doi: 10.1093/fampra/cmu028
[21]	Barry JA, Kuczmierczyk AR, Hardiman PJ (2011) Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 26: 2442-2451. doi: 10.1093/humrep/der197
[22]	Blay SL, Aguiar JV, Passos IC (2016) Polycystic ovary syndrome and mental disorders: a systematic review and exploratory meta-analysis. Neuropsychiatr Dis Treat 12: 2895-2903. doi: 10.2147/NDT.S91700
[23]	Brutocao C, Zaiem F, Alsawas M, et al. (2018) Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysis. Endocrine 62: 318-325. doi: 10.1007/s12020-018-1692-3
[24]	Cooney LG, Lee I, Sammel MD, et al. (2017) High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 32: 1075-1091. doi: 10.1093/humrep/dex044
[25]	Damone AL, Joham AE, Loxton D, et al. (2019) Depression, anxiety and perceived stress in women with and without PCOS: a community-based study. Psychol Med 49: 1510-1520. doi: 10.1017/S0033291718002076
[26]	Dokras A, Stener-Victorin E, Yildiz BO, et al. (2018) Androgen Excess-Polycystic Ovary Syndrome Society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome. Fertil Steril 109: 888-899. doi: 10.1016/j.fertnstert.2018.01.038
[27]	Banting LK, Gibson-Helm M, Polman R, et al. (2014) Physical activity and mental health in women with polycystic ovary syndrome. BMC Women's Health 14: 51. doi: 10.1186/1472-6874-14-51
[28]	Lamb JD, Johnstone EB, Rousseau JA, et al. (2011) Physical activity in women with polycystic ovary syndrome: prevalence, predictors, and positive health association. Am J Obstet Gynecol 204: 352.e1-352.e6. doi: 10.1016/j.ajog.2010.12.006
[29]	Gibson-Helm M, Teede H, Dunaif A, et al. (2017) Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 102: 604-612.
[30]	Pasquali R (2018) Contemporary approaches to the management of polycystic ovary syndrome. Ther Adv Endocrinol Metab 9: 123-134. doi: 10.1177/2042018818756790
[31]	Johnson NP (2014) Metformin use in women with polycystic ovary syndrome. Ann Transl Med 2: 56.
[32]	Middleton KR, Anton SD, Perri MG (2013) Long-term adherence to health behavior change. Am J Lifestyle Med 7: 395-404. doi: 10.1177/1559827613488867
[33]	Seo DC, Sa J (2008) A meta-analysis of psycho-behavioral obesity interventions among US multiethnic and minority adults. Prev Med 47: 573-582. doi: 10.1016/j.ypmed.2007.12.010
[34]	Welschen LM, van Oppen P, Dekker JM, et al. (2007) The effectiveness of adding cognitive behavioural therapy aimed at changing lifestyle to managed diabetes care for patients with type 2 diabetes: design of a randomised controlled trial. BMC Public Health 7: 74. doi: 10.1186/1471-2458-7-74
[35]	Moran LJ, Ko H, Misso M, et al. (2013) Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines. J Acad Nutr Diet 113: 520-545. doi: 10.1016/j.jand.2012.11.018
[36]	Zhang X, Zheng Y, Guo Y, et al. (2019) The Effect of low carbohydrate diet on polycystic ovary syndrome: A meta-analysis of randomized controlled trials. Int J Endocrinol 2019: 1-14.
[37]	Farshchi H, Rane A, Love A, et al. (2007) Diet and nutrition in polycystic ovary syndrome (PCOS): pointers for nutritional management. J Obstet Gyneacol 27: 762-773. doi: 10.1080/01443610701667338
[38]	Ko H, Teede H, Moran L (2016) Analysis of the barriers and enablers to implementing lifestyle management practices for women with PCOS in Singapore. BMC Res Notes 9: 311. doi: 10.1186/s13104-016-2107-2
[39]	Racic M, Pekez-Pavlisko T, Jokovic S (2018) Barriers and facilitators for implementation of family medicine-oriented model of primary care in Bosnia and Herzegovina: A qualitative study. Int J Health Plann Manage 33: e378-e390. doi: 10.1002/hpm.2470
[40]	Fang F, Ni K, Cai Y, et al. (2017) Effect of vitamin D supplementation on polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials. Complement Ther Clin Pract 26: 53-60. doi: 10.1016/j.ctcp.2016.11.008
[41]	Jamilian M, Foroozanfard F, Rahmani E, et al. (2017) Effect of two different doses of vitamin D supplementation on metabolic profiles of insulin-resistant patients with polycystic ovary syndrome. Nutrients 9: 1280. doi: 10.3390/nu9121280
[42]	Menichini D, Facchinetti F (2020) Effects of vitamin D supplementation in women with polycystic ovary syndrome: a review. Gynecol Endocrinol 36: 1-5. doi: 10.1080/09513590.2019.1625881
[43]	Kadoura S, Alhalabi M, Nattouf AH (2019) Effect of calcium and vitamin D supplements as an adjuvant therapy to metformin on menstrual cycle abnormalities, hormonal profile, and IGF-1 system in polycystic ovary syndrome patients: a randomized, placebo-controlled clinical trial. Adv Pharmacol Sci 2019.
[44]	Foroozanfard F, Jamilian M, Bahmani F, et al. (2015) Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. Clin Endocrinol (Oxf) 83: 888-894. doi: 10.1111/cen.12840
[45]	Tehrani HG, Mostajeran F, Shahsavari S (2014) The effect of calcium and vitamin D supplementation on menstrual cycle, body mass index and hyperandrogenism state of women with polycystic ovarian syndrome. J Res Med Sci 19: 875-880.
[46]	Izadi A, Ebrahimi S, Shirazi S, et al. (2019) Hormonal and metabolic effects of coenzyme Q10 and/or vitamin E in patients with polycystic ovary syndrome. J Clin Endocrinol Metab 104: 319-327.
[47]	Izadi A, Shirazi S, Taghizadeh S, et al. (2019) Independent and additive effects of coenzyme Q10 and vitamin E on cardiometabolic outcomes and visceral adiposity in women with polycystic ovary syndrome. Arch Med Res 50: 1-10. doi: 10.1016/j.arcmed.2019.04.004
[48]	Talari HR, Poladchang S, Hamidian Y, et al. (2018) The effects of omega-3 and vitamin E co-supplementation on carotid intima-media thickness and inflammatory factors in patients with polycystic ovary syndrome. Oman Med J 33: 473-479. doi: 10.5001/omj.2018.88
[49]	Ebrahimi FA, Samimi M, Foroozanfard F, et al. (2017) The effects of omega-3 fatty acids and vitamin E co-supplementation on indices of insulin resistance and hormonal parameters in patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Exp Clin Endocrinol Diabetes 125: 353-359. doi: 10.1055/s-0042-117773

publichealth-07-03-041-s001.pdf

This article has been cited by:

1.	Impact of vaccine arrival on the optimal control of a newly emerging infectious disease: A theoretical study, 2012, 9, 1551-0018, 539, 10.3934/mbe.2012.9.539
2.	Bruno Buonomo, Modeling ITNs Usage: Optimal Promotion Programs Versus Pure Voluntary Adoptions, 2015, 3, 2227-7390, 1241, 10.3390/math3041241
3.	Hamadjam Abboubakar, Jean Claude Kamgang, Leontine Nkague Nkamba, Daniel Tieudjo, Bifurcation thresholds and optimal control in transmission dynamics of arboviral diseases, 2018, 76, 0303-6812, 379, 10.1007/s00285-017-1146-1
4.	Benjamin Riche, Hélène Bricout, Marie-Laure Kürzinger, Sylvain Roche, Jean Iwaz, Jean-François Etard, René Ecochard, Modeling and predicting the long-term effects of various strategies and objectives of varicella-zoster vaccination campaigns, 2016, 15, 1476-0584, 927, 10.1080/14760584.2016.1183483
5.	Lingcai Kong, Jinfeng Wang, Weiguo Han, Zhidong Cao, Modeling Heterogeneity in Direct Infectious Disease Transmission in a Compartmental Model, 2016, 13, 1660-4601, 253, 10.3390/ijerph13030253
6.	Nkengafac Villyen Motaze, Zinhle E. Mthombothi, Olatunji Adetokunboh, C. Marijn Hazelbag, Enrique M. Saldarriaga, Lawrence Mbuagbaw, Charles Shey Wiysonge, The Impact of Rubella Vaccine Introduction on Rubella Infection and Congenital Rubella Syndrome: A Systematic Review of Mathematical Modelling Studies, 2021, 9, 2076-393X, 84, 10.3390/vaccines9020084
7.	BRUNO BUONOMO, ON THE OPTIMAL VACCINATION STRATEGIES FOR HORIZONTALLY AND VERTICALLY TRANSMITTED INFECTIOUS DISEASES, 2011, 19, 0218-3390, 263, 10.1142/S0218339011003853
8.	Bruno Buonomo, 2014, Chapter 3, 978-3-319-06922-7, 23, 10.1007/978-3-319-06923-4_3
9.	Chairat Modnak, Jin Wang, Zindoga Mukandavire, Simulating optimal vaccination times during cholera outbreaks, 2014, 07, 1793-5245, 1450014, 10.1142/S1793524514500144
10.	Drew Posny, Jin Wang, Zindoga Mukandavire, Chairat Modnak, Analyzing transmission dynamics of cholera with public health interventions, 2015, 264, 00255564, 38, 10.1016/j.mbs.2015.03.006
11.	Matt J. Keeling, Andrew Shattock, Optimal but unequitable prophylactic distribution of vaccine, 2012, 4, 17554365, 78, 10.1016/j.epidem.2012.03.001
12.	Bruno Buonomo, Cruz Vargas-De-León, Effects of Mosquitoes Host Choice on Optimal Intervention Strategies for Malaria Control, 2014, 132, 0167-8019, 127, 10.1007/s10440-014-9894-z
13.	Bruno Buonomo, Piero Manfredi, Alberto d’Onofrio, Optimal time-profiles of public health intervention to shape voluntary vaccination for childhood diseases, 2019, 78, 0303-6812, 1089, 10.1007/s00285-018-1303-1
14.	Adison Thongtha, Chairat Modnak, Optimal COVID-19 epidemic strategy with vaccination control and infection prevention measures in Thailand, 2022, 7, 24680427, 835, 10.1016/j.idm.2022.11.002
15.	Calvin Tadmon, Arnaud Feukouo Fossi, Berge Tsanou, A two–strain avian–human influenza model with environmental transmission: Stability analysis and optimal control strategies, 2024, 10075704, 107981, 10.1016/j.cnsns.2024.107981
16.	Gui Guan, Zhenyuan Guo, Yanyu Xiao, Dynamical behaviors of a network-based SIR epidemic model with saturated incidence and pulse vaccination, 2024, 137, 10075704, 108097, 10.1016/j.cnsns.2024.108097
17.	Samiullah Salim, Fazal Dayan, Muhammad Azizur Rehman, Husam A. Neamah, Optimization and Control in Rubella Transmission Dynamics: A Boundedness-Preserving Numerical Model with Vaccination, 2024, 23529148, 101595, 10.1016/j.imu.2024.101595
18.	Habtamu Ayalew Engida, Demeke Fisseha, Malaria and leptospirosis co-infection: A mathematical model analysis with optimal control and cost-effectiveness analysis, 2025, 24682276, e02517, 10.1016/j.sciaf.2024.e02517
19.	Giovanni Ziarelli, Stefano Pagani, Nicola Parolini, Francesco Regazzoni, Marco Verani, A model learning framework for inferring the dynamics of transmission rate depending on exogenous variables for epidemic forecasts, 2025, 437, 00457825, 117796, 10.1016/j.cma.2025.117796

Reader Comments

Your name:*

Email:*
© 2020 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)